Administrative Core

行政核心

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT– ADMINISTRATIVE CORE The primary objective of the Administrative Core is to ensure the effective integration and interaction of the scientists and other personnel working on the Projects and Scientific Cores that comprise this PPG. First, the Core establishes the scientific priorities and directions of the research through regular meetings of the PPG’s Executive Committee. Second, the Core is responsible for administering the day-to-day activities of the PPG, including the monitoring of all budgets, submission of progress reports, and adherence to regulatory requirements associated with our research. Third, the Core coordinates the many modes of communication among PPG investigators, including regular meetings, work-in-progress seminars, and interactions with our Internal Advisory Committee, that ensure our cohesive research program. Likewise, the Core supports visits to New York by members of our External Advisory Committee, and key consultants, to meet with PPG faculty and trainees and review the progress of our research. Fourth, the Core maintains a creative PPG website to foster communication not only among PPG investigators, but also with the scientific community and general public at large. Such communication includes resource and data sharing and the dissemination of vast amounts of genome-wide gene expression and chromatin data as rapidly as possible as well as enabling the free download of novel PPG software designed to analyze complex datasets. Fifth, the Core fosters several additional outreach efforts to patient advocacy and community organizations. Sixth, the Core, through the Executive Committee, works to ensure the successful career paths of numerous students and postdoctoral trainees. We expect numerous individual R and K grants and NRSAs to be generated by the PPG's research. Such career development focuses in particular on the recruitment and retention of women and of scientists from under-represented groups; we are proud of our track record in this regard. Seventh, the Core is responsible, in collaboration with our various training programs, to ensure the safe and ethical conduct of research with the highest rigor. Joining together effectively to form a unified research team is key to the success of this large undertaking, and we are confident in our ability to accomplish this goal.
项目概要/摘要——行政核心 行政核心的首要目标是确保各部门的有效整合和互动 从事构成该 PPG 的项目和科学核心的科学家和其他人员。 Core 通过 PPG 的定期会议确定研究的科学重点和方向 其次,核心负责管理 PPG 的日常活动, 包括监测所有预算、提交进度报告以及遵守监管规定 第三,核心协调多种沟通模式。 PPG 调查人员之间的交流,包括定期会议、正在进行的研讨会以及与我们的互动 内部咨询委员会,确保我们的研究计划具有凝聚力,同样,核心支持访问。 我们的外部咨询委员会成员和主要顾问在纽约会见 PPG 教职员工和 第四,核心维护一个富有创意的 PPG 网站,以促进培​​训。 不仅在 PPG 研究人员之间进行沟通,而且还与科学界和公众进行沟通 这种交流包括资源和数据共享以及大量信息的传播。 尽快获得全基因组基因表达和染色质数据,并实现免费 下载旨在分析复杂数据集的新型 PPG 软件。第五,核心培育了多种数据集。 第六,通过核心,向患者倡导和社区组织开展额外的外展工作。 执行委员会致力于确保众多学生和博士后的成功职业道路 我们预计 PPG 的研究将产生大量个人 R 和 K 资助以及 NRSA。 这种职业发展特别注重招募和保留女性和科学家 来自代表性不足的群体;我们对我们在这方面的记录感到自豪第七,核心是。 负责与我们的各种培训计划合作,确保安全和道德的行为 高度严谨的研究 有效地联合起来形成一个统一的研究团队是实现这一目标的关键。 这项伟大事业的成功,我们对实现这一目标的能力充满信心。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC J. NESTLER其他文献

ERIC J. NESTLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC J. NESTLER', 18)}}的其他基金

Epigenetic Mechanisms of Chronic Stress Action
慢性应激作用的表观遗传机制
  • 批准号:
    10583621
  • 财政年份:
    2022
  • 资助金额:
    $ 6.07万
  • 项目类别:
Transcriptional Mechanisms of Drug Addiction
毒瘾的转录机制
  • 批准号:
    10306364
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10062500
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Novel Transcription Factors in Stimulant and Opiate Action
兴奋剂和阿片类药物作用中的新型转录因子
  • 批准号:
    10062504
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Transcriptional Mechanisms of Drug Addiction
毒瘾的转录机制
  • 批准号:
    10533283
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10306365
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Novel Transcription Factors in Stimulant and Opiate Action
兴奋剂和阿片类药物作用中的新型转录因子
  • 批准号:
    10306368
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Transcriptional Mechanisms of Drug Addiction
毒瘾的转录机制
  • 批准号:
    9926434
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Novel Transcription Factors in Stimulant and Opiate Action
兴奋剂和阿片类药物作用中的新型转录因子
  • 批准号:
    10533293
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:
Transcriptional Mechanisms of Drug Addiction
毒瘾的转录机制
  • 批准号:
    10062498
  • 财政年份:
    2019
  • 资助金额:
    $ 6.07万
  • 项目类别:

相似海外基金

Pragmatic Implementation Science Approaches to Assess and Enhance Value of Cancer Prevention and Control in Rural Primary Care
务实实施科学方法评估和提高农村初级保健癌症预防和控制的价值
  • 批准号:
    10942883
  • 财政年份:
    2023
  • 资助金额:
    $ 6.07万
  • 项目类别:
Immune determinants of pediatric HIV/SIV reservoir establishment and maintenance
儿科 HIV/SIV 病毒库建立和维持的免疫决定因素
  • 批准号:
    10701468
  • 财政年份:
    2023
  • 资助金额:
    $ 6.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10912268
  • 财政年份:
    2023
  • 资助金额:
    $ 6.07万
  • 项目类别:
Integrated Supported Biopsychosocial Self-Management for Back Related Leg Pain (SUPPORT trial)
针对背部相关腿痛的综合支持性生物心理社会自我管理(SUPPORT 试验)
  • 批准号:
    10365290
  • 财政年份:
    2021
  • 资助金额:
    $ 6.07万
  • 项目类别:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
  • 批准号:
    10263250
  • 财政年份:
    2020
  • 资助金额:
    $ 6.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了